BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28635233)

  • 21. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
    Kebebew E; Greenspan FS; Clark OH; Woeber KA; McMillan A
    Cancer; 2005 Apr; 103(7):1330-5. PubMed ID: 15739211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
    Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
    Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002.
    Chen J; Tward JD; Shrieve DC; Hitchcock YJ
    Am J Clin Oncol; 2008 Oct; 31(5):460-4. PubMed ID: 18838882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results of radiotherapy in anaplastic thyroid cancer.
    Dumke AK; Pelz T; Vordermark D
    Radiat Oncol; 2014 Mar; 9(1):90. PubMed ID: 24685141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy Plus Chemotherapy Leads to Prolonged Survival in Patients With Anaplastic Thyroid Cancer Compared With Radiotherapy Alone Regardless of Surgical Resection and Distant Metastasis: A Retrospective Population Study.
    Zhou W; Yue Y; Zhang X
    Front Endocrinol (Lausanne); 2021; 12():748023. PubMed ID: 34790169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer: A Single-Institution 21-Year Experience.
    Wu SS; Lamarre ED; Yalamanchali A; Brauer PR; Hong H; Reddy CA; Yilmaz E; Woody N; Ku JA; Prendes B; Burkey B; Nasr C; Skugor M; Heiden K; Chute DJ; Knauf JA; Campbell SR; Koyfman SA; Geiger JL; Scharpf J
    JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):300-309. PubMed ID: 36757708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of combined treatment for anaplastic thyroid carcinoma: results of a multinstitutional retrospective analysis.
    Conzo G; Polistena A; Calò PG; Bononi P; Gambardella C; Mauriello C; Tartaglia E; Avenia S; Sanguinetti A; Medas F; de Toma G; Avenia N
    Int J Surg; 2014; 12 Suppl 1():S178-82. PubMed ID: 24866070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery.
    Jacobsen AB; Grøholt KK; Lorntzsen B; Osnes TA; Falk RS; Sigstad E
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4203-4209. PubMed ID: 29019001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
    Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
    Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing outcomes in poorly-differentiated versus anaplastic thyroid cancers treated with radiation: a surveillance, epidemiology, and end results analysis.
    Arora S; Christos P; Pham A; Desai P; Wernicke AG; Nori D; Chao KS; Parashar B
    J Cancer Res Ther; 2014; 10(3):526-30. PubMed ID: 25313732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
    Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
    Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma.
    Lee DY; Won JK; Choi HS; Park do J; Jung KC; Sung MW; Kim KH; Hah JH; Park YJ
    Thyroid; 2016 Sep; 26(9):1259-68. PubMed ID: 27412715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of 37 patients with anaplastic carcinoma of the thyroid.
    Kobayashi T; Asakawa H; Umeshita K; Takeda T; Maruyama H; Matsuzuka F; Monden M
    Head Neck; 1996; 18(1):36-41. PubMed ID: 8774920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China.
    Sun C; Li Q; Hu Z; He J; Li C; Li G; Tao X; Yang A
    PLoS One; 2013; 8(11):e80011. PubMed ID: 24224029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
    Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
    Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival Benefit of Intervention Treatment in Advanced Anaplastic Thyroid Cancer.
    Kasemsiri P; Chaisakgreenon P; Vatanasapt P; Laohasiriwong S; Teeramatwanich W; Thongrong C; Ratanaanekchai T; Suetrong S
    Int J Surg Oncol; 2021; 2021():5545127. PubMed ID: 34123423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.